Sustained long-term clinical effectiveness of subcutaneous allergen immunotherapy to house dust mites

被引：0
|
作者：
Garcia-Robaina, J. C. [1 ]
Ruiz Garcia, M. [2 ]
Sanchez-Lopez, J. [3 ]
机构：
[1] Hosp Univ Candelaria, Santa Cruz De Tenerife, Spain
[2] Labs LETI SLU, Madrid, Spain
[3] Labs LETI SLU, Barcelona, Spain
来源：
ALLERGY | 2020年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0776
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of the subcutaneous house dust mite allergen immunotherapy plus pharmacotherapy for allergic asthma: A mathematical model
    Parra-Padilla, Devian
    Zakzuk, Josefina
    Carrasquilla, Maria
    Alvis-Guzman, Nelson
    Dennis, Rodolfo
    Rojas, Maria X.
    Rondon, Martin
    Perez, Adriana
    Penaranda, Augusto
    Barragan, Ana M.
    Caraballo, Luis
    Garcia, Elizabeth
    ALLERGY, 2021, 76 (07) : 2229 - 2233
  • [32] Effectiveness and tolerability of sublingual allergen immunotherapy (ait) with or without titration in routine medical practice in house dust mites allergic patients
    Singh, J.
    Park, S.
    Shah-Hosseini, K.
    Compalati, E.
    Mosges, R.
    ALLERGY, 2017, 72 : 486 - 486
  • [33] INFLUENCE OF LONG-TERM HOUSE DUST MITES EXPOSURE ON ASTHMA AND SKIN REACTIONS PREVALENCE
    CHARPIN, J
    CHARPIN, D
    VERVLOET, D
    RAZZOUK, H
    KLEISBAUER, JP
    LANTEAUME, A
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (01) : 183 - 183
  • [34] Long-term exposure to house dust mites accelerates lung cancer development in mice
    Dongjie Wang
    Wen Li
    Natalie Albasha
    Lindsey Griffin
    Han Chang
    Lauren Amaya
    Sneha Ganguly
    Liping Zeng
    Bora Keum
    José M. González-Navajas
    Matt Levin
    Zohreh AkhavanAghdam
    Helen Snyder
    David Schwartz
    Ailin Tao
    Laela M. Boosherhri
    Hal M. Hoffman
    Michael Rose
    Monica Valeria Estrada
    Nissi Varki
    Scott Herdman
    Maripat Corr
    Nicholas J. G. Webster
    Eyal Raz
    Samuel Bertin
    Journal of Experimental & Clinical Cancer Research, 42
  • [35] Long-term exposure to house dust mites accelerates lung cancer development in mice
    Wang, Dongjie
    Li, Wen
    Albasha, Natalie
    Griffin, Lindsey
    Chang, Han
    Amaya, Lauren
    Ganguly, Sneha
    Zeng, Liping
    Keum, Bora
    Gonzalez-Navajas, Jose M.
    Levin, Matt
    AkhavanAghdam, Zohreh
    Snyder, Helen
    Schwartz, David
    Tao, Ailin
    Boosherhri, Laela M.
    Hoffman, Hal M.
    Rose, Michael
    Estrada, Monica Valeria
    Varki, Nissi
    Herdman, Scott
    Corr, Maripat
    Webster, Nicholas J. G.
    Raz, Eyal
    Bertin, Samuel
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [36] Molecular Profile Sensitization to House Dust Mites as an Important Aspect for Predicting the Efficiency of Allergen Immunotherapy
    Rodinkova, Victoria V.
    Yuriev, Serhii D.
    Kryvopustova, Mariia V.
    Mokin, Vitalii B.
    Kryzhanovskyi, Yevhenii M.
    Kurchenko, Andrii I.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Effectiveness of allergen immunotherapy with house dust mite extract for pediatric bronchial asthma
    Hamada, Masaaki
    Saeki, Keigo
    Tanaka, Ichiro
    IMMUNOTHERAPY, 2024, 16 (08) : 539 - 549
  • [38] Early effectiveness of allergen immunotherapy in children with asthma allergic to house dust mite
    Sobocinska, Agnieszka
    Majak, Pawel
    Jerzynska, Joanna
    Ozarek-Hanc, Agata
    Stelmach, Iwona
    ALERGIA ASTMA IMMUNOLOGIA, 2012, 17 (01): : 27 - 31
  • [39] Long-term clinical efficacy of HDM allergen immunotherapy in allergic rhinitis
    Liu, X.
    Sun, B.
    Zheng, P.
    ALLERGY, 2019, 74 : 191 - 192
  • [40] Clinical trial to assess tolerability and subrogate efficacy effects of an abbreviated schedule with house dust mites mixture subcutaneous immunotherapy
    Antepara, I
    Roger, A.
    Bernedo, N.
    Lleonart, R.
    Rodriguez, F.
    Madariaga, B.
    Asturias, J. A.
    Begona, L.
    Martinez, A.
    Landeta, A.
    Gomez-Fernandez, M. C.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 53 (02) : 67 - 74
12345